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Intracellular localisation of mTHPC and effect of photodynamic 
therapy in cells of the mammalian peripheral nervous system 
 
Fewer nerve-related side effects have been noted after treating head 
and neck cancer with photodynamic therapy (PDT) compared to 
conventional cancer therapy. Our aim is to investigate the biological basis 
for any such nerve-sparing effect. In this study the intracellular 
localisation and effect on cell viability of the photosensitiser meta-
tetrahydroxylphenylchlorin (mTHPC) was investigated in cell culture 
models using peripheral nerve cells. 
Primary cells from adult rat dorsal root ganglia (containing both 
neurons and glia) were used in these experiments. Localisation of 
mTHPC was detected using fluorescence and confocal microscopy. 
Levels of mTHPC fluorescence were quantified using digital image 
analysis. Immunocytochemistry with anti-β-III-tubulin and anti-S100 was 
used to distinguish neuronal and glial cell populations respectively. A 
cell-death assay using propidium iodide was used to evaluate neural cell 
susceptibility to PDT following incubation with mTHPC. 
The results showed that mTHPC was localised in cytoplasmic 
regions of neurons and glia, but was not detected in neuronal axons. 
Necrotic cell death was detected after PDT in these neural cell types. 
These results suggest that the cells of the peripheral nervous 
system are susceptible to PDT-mediated necrosis, but that the sparing of 
nerves observed during clinical PDT may be related to the heterogeneous 
distribution of mTHPC within neurons.  
